Description
BIC-EMTAF Tablet contains bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg. It is a prescription antiretroviral medicine used to treat HIV-1 infection. It helps reduce viral replication and control the amount of HIV in the body but does not cure HIV.
Strength: 50 mg + 200 mg + 25 mg
Marketed by: Emcure
Pack Size: 30 tablets
Uses of BIC-EMTAF Tablet
- Treatment of HIV-1 infection in eligible patients.
How BIC-EMTAF Tablet Works
Bictegravir blocks the HIV integrase enzyme, while emtricitabine and tenofovir alafenamide inhibit reverse transcriptase. Together, they prevent HIV from multiplying and help reduce viral load.
Benefits
- Helps suppress HIV-1 viral load.
- Supports immune-system function.
- Provides three antiretroviral medicines in one tablet.
Dosage and Directions
Take one tablet once daily, or as prescribed by your doctor. It can generally be taken with or without food. Take it at the same time each day and swallow it whole with water.
Your doctor may check for hepatitis B infection and review your kidney, liver, and overall medical history before treatment.
Drug Interactions and Precautions
Tell your doctor about all medicines, supplements, and herbal products you take. Also inform them about allergies, kidney or liver problems, or other medical conditions. Some medicines may interact with BIC-EMTAF and affect its safety or effectiveness.
Storage
Store BIC-EMTAF at room temperature, away from heat, moisture, and direct sunlight. Keep it out of reach of children and pets.



Reviews
There are no reviews yet.